CAPITOL COUNSEL LLC

Lobbying for ARDELYX, INC. · Biopharmaceutical company.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 19, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues regarding ESRD-related drugs and the Medicare ESRD prospective payment system.

Medicare/Medicaid

Issues regarding ESRD-related drugs and the Medicare ESRD prospective payment system.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.